메뉴 건너뛰기




Volumn 10, Issue 3, 2016, Pages 708-713

Hybrid Closed-Loop Insulin Delivery in Type 1 Diabetes during Supervised Outpatient Conditions

Author keywords

artificial pancreas; diabetes; human trials; insulin pump therapy

Indexed keywords

GLUCOSE; INSULIN; ANTIDIABETIC AGENT;

EID: 85009513411     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/1932296816631568     Document Type: Article
Times cited : (35)

References (21)
  • 1
    • 84899117172 scopus 로고    scopus 로고
    • Overnight closed-loop insulin delivery in young people with type 1 diabetes: A free-living, randomized clinical trial
    • Hovorka R, Elleri D, Thabit H, et al. Overnight closed-loop insulin delivery in young people with type 1 diabetes: a free-living, randomized clinical trial. Diabetes Care. 2014; 37: 1204-1211.
    • (2014) Diabetes Care , vol.37 , pp. 1204-1211
    • Hovorka, R.1    Elleri, D.2    Thabit, H.3
  • 2
    • 84959575709 scopus 로고    scopus 로고
    • Unsupervised overnight closed loop insulin delivery during free living: Analysis of randomised cross-over home studies in adults and adolescents with type 1 diabetes
    • Thabit H, Elleri D, Leelarathna L, et al. Unsupervised overnight closed loop insulin delivery during free living: analysis of randomised cross-over home studies in adults and adolescents with type 1 diabetes. Lancet. 2015; 385 (suppl 1): S96.
    • (2015) Lancet , vol.385 , pp. S96
    • Thabit, H.1    Elleri, D.2    Leelarathna, L.3
  • 3
    • 84926223235 scopus 로고    scopus 로고
    • Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes
    • Del Favero S, Place J, Kropff J, et al. Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes. Diabetes Obes Metab. 2015; 17: 468-476.
    • (2015) Diabetes Obes Metab , vol.17 , pp. 468-476
    • Del Favero, S.1    Place, J.2    Kropff, J.3
  • 4
    • 84923879450 scopus 로고    scopus 로고
    • Multinight "bedside" closed-loop control for patients with type 1 diabetes
    • Brown SA, Kovatchev BP, Breton MD, et al. Multinight "bedside" closed-loop control for patients with type 1 diabetes. Diabetes Technol Ther. 2015; 17: 203-209.
    • (2015) Diabetes Technol Ther , vol.17 , pp. 203-209
    • Brown, S.A.1    Kovatchev, B.P.2    Breton, M.D.3
  • 5
    • 84926165827 scopus 로고    scopus 로고
    • Unsupervised home use of an overnight closed-loop system over 3-4 weeks: A pooled analysis of randomized controlled studies in adults and adolescents with type 1 diabetes
    • Thabit H, Elleri D, Leelarathna L, et al. Unsupervised home use of an overnight closed-loop system over 3-4 weeks: a pooled analysis of randomized controlled studies in adults and adolescents with type 1 diabetes. Diabetes Obes Metab. 2015; 17: 452-458.
    • (2015) Diabetes Obes Metab , vol.17 , pp. 452-458
    • Thabit, H.1    Elleri, D.2    Leelarathna, L.3
  • 6
    • 84910135134 scopus 로고    scopus 로고
    • MD-Logic overnight control for 6 weeks of home use in patients with type 1 diabetes: Randomized crossover trial
    • Nimri R, Muller I, Atlas E, et al. MD-Logic overnight control for 6 weeks of home use in patients with type 1 diabetes: randomized crossover trial. Diabetes Care. 2014; 37: 3025-3032.
    • (2014) Diabetes Care , vol.37 , pp. 3025-3032
    • Nimri, R.1    Muller, I.2    Atlas, E.3
  • 7
    • 84948082694 scopus 로고    scopus 로고
    • 2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: A randomised crossover trial
    • Kropff J, Del Favero S, Place J, et al. 2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial. Lancet Diabetes Endocrinol. 2015; 3: 939-947.
    • (2015) Lancet Diabetes Endocrinol , vol.3 , pp. 939-947
    • Kropff, J.1    Del Favero, S.2    Place, J.3
  • 8
    • 84948440168 scopus 로고    scopus 로고
    • Day and night closed-loop control using the integrated Medtronic hybrid closed-loop system in type 1 diabetes at diabetes camp
    • Ly TT, Roy A, Grosman B, et al. Day and night closed-loop control using the integrated Medtronic hybrid closed-loop system in type 1 diabetes at diabetes camp. Diabetes Care. 2015; 38: 1205-1211.
    • (2015) Diabetes Care , vol.38 , pp. 1205-1211
    • Ly, T.T.1    Roy, A.2    Grosman, B.3
  • 9
    • 84904574791 scopus 로고    scopus 로고
    • Outpatient glycemic control with a bionic pancreas in type 1 diabetes
    • Russell SJ, El-Khatib FH, Sinha M, et al. Outpatient glycemic control with a bionic pancreas in type 1 diabetes. N Engl J Med. 2014; 371: 313-325.
    • (2014) N Engl J Med , vol.371 , pp. 313-325
    • Russell, S.J.1    El-Khatib, F.H.2    Sinha, M.3
  • 10
    • 84899108319 scopus 로고    scopus 로고
    • First use of model predictive control in outpatient wearable artificial pancreas
    • Del Favero S, Bruttomesso D, Di Palma F, et al. First use of model predictive control in outpatient wearable artificial pancreas. Diabetes Care. 2014; 37: 1212-1215.
    • (2014) Diabetes Care , vol.37 , pp. 1212-1215
    • Del Favero, S.1    Bruttomesso, D.2    Di Palma, F.3
  • 11
    • 84903551043 scopus 로고    scopus 로고
    • Safety of outpatient closed-loop control: First randomized crossover trials of a wearable artificial pancreas
    • Kovatchev BP, Renard E, Cobelli C, et al. Safety of outpatient closed-loop control: first randomized crossover trials of a wearable artificial pancreas. Diabetes Care. 2014; 37: 1789-1796.
    • (2014) Diabetes Care , vol.37 , pp. 1789-1796
    • Kovatchev, B.P.1    Renard, E.2    Cobelli, C.3
  • 12
    • 84903547471 scopus 로고    scopus 로고
    • Day and night home closed-loop insulin delivery in adults with type 1 diabetes: Three-center randomized crossover study
    • Leelarathna L, Dellweg S, Mader JK, et al. Day and night home closed-loop insulin delivery in adults with type 1 diabetes: three-center randomized crossover study. Diabetes Care. 2014; 37: 1931-1937.
    • (2014) Diabetes Care , vol.37 , pp. 1931-1937
    • Leelarathna, L.1    Dellweg, S.2    Mader, J.K.3
  • 13
    • 84904574791 scopus 로고    scopus 로고
    • Outpatient glycemic control with a bionic pancreas in type 1 diabetes
    • Russell SJ, El-Khatib FH, Sinha M, et al. Outpatient glycemic control with a bionic pancreas in type 1 diabetes. N Engl J Med. 2014; 371: 313-325.
    • (2014) N Engl J Med , vol.371 , pp. 313-325
    • Russell, S.J.1    El-Khatib, F.H.2    Sinha, M.3
  • 14
    • 84946427627 scopus 로고    scopus 로고
    • Home use of an artificial beta cell in type 1 diabetes
    • Thabit H, Tauschmann M, Allen JM, et al. Home use of an artificial beta cell in type 1 diabetes. N Engl J Med. 2015; 373: 2129-2140.
    • (2015) N Engl J Med , vol.373 , pp. 2129-2140
    • Thabit, H.1    Tauschmann, M.2    Allen, J.M.3
  • 15
    • 79955670667 scopus 로고    scopus 로고
    • The effect of insulin feedback on closed loop glucose control
    • Steil GM, Palerm CC, Kurtz N, et al. The effect of insulin feedback on closed loop glucose control. J Clin Endocrinol Metab. 2011; 96: 1402-1408.
    • (2011) J Clin Endocrinol Metab , vol.96 , pp. 1402-1408
    • Steil, G.M.1    Palerm, C.C.2    Kurtz, N.3
  • 16
    • 0032962321 scopus 로고    scopus 로고
    • A model-based algorithm for blood glucose control in Type i diabetic patients
    • Parker RS, Doyle FJ, Peppas NA., A model-based algorithm for blood glucose control in Type I diabetic patients. IEEE Trans Biomed Engineer. 1999; 46: 148-157.
    • (1999) IEEE Trans Biomed Engineer , vol.46 , pp. 148-157
    • Parker, R.S.1    Doyle, F.J.2    Peppas, N.A.3
  • 17
    • 77954901769 scopus 로고    scopus 로고
    • MD-logic artificial pancreas system: A pilot study in adults with type 1 diabetes
    • Atlas E, Nimri R, Miller S, Grunberg EA, Phillip M., MD-logic artificial pancreas system: a pilot study in adults with type 1 diabetes. Diabetes Care. 2010; 33: 1072-1076.
    • (2010) Diabetes Care , vol.33 , pp. 1072-1076
    • Atlas, E.1    Nimri, R.2    Miller, S.3    Grunberg, E.A.4    Phillip, M.5
  • 19
    • 84875188726 scopus 로고    scopus 로고
    • Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: A randomized crossover controlled trial
    • Haidar A, Legault L, Dallaire M, et al. Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial. CMAJ. 2013; 185: 297-305.
    • (2013) CMAJ , vol.185 , pp. 297-305
    • Haidar, A.1    Legault, L.2    Dallaire, M.3
  • 20
    • 84866727216 scopus 로고    scopus 로고
    • Effect of pramlintide on prandial glycemic excursions during closed-loop control in adolescents and young adults with type 1 diabetes
    • Weinzimer SA, Sherr JL, Cengiz E, et al. Effect of pramlintide on prandial glycemic excursions during closed-loop control in adolescents and young adults with type 1 diabetes. Diabetes Care. 2012; 35: 1994-1999.
    • (2012) Diabetes Care , vol.35 , pp. 1994-1999
    • Weinzimer, S.A.1    Sherr, J.L.2    Cengiz, E.3
  • 21
    • 80655141686 scopus 로고    scopus 로고
    • Closed-loop insulin delivery for treatment of type 1 diabetes
    • Elleri D, Dunger D, Hovorka R., Closed-loop insulin delivery for treatment of type 1 diabetes. BMC Med. 2011; 9: 120.
    • (2011) BMC Med , vol.9 , pp. 120
    • Elleri, D.1    Dunger, D.2    Hovorka, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.